HEMOLYTIC ANEMIA IMUNNE-MEDIATED IN DOGS

• Main Authors: R. C. Castilho, M. O. Lima, M. F. R. Cruz, E. S. Marquez, C. Calderón
• Format: Article
• Language: English
• Published: Universidade Federal de Rondonópolis 2016-11-01
• Series: Scientific Electronic Archives
• Subjects: IMHA; immune suystem; dogs
• Online Access: http://www.seasinop.com.br/revista/index.php?journal=SEA&page=article&op=view&path%5B%5D=288&path%5B%5D=pdf

Due to the reduction in the number of red blood cells, caused by the immune system, the immune-mediated hemolytic anemia (IMHA) is the most common disease among the hemolytic anemias and occurs more frequently in dogs (Nelson & Couto, 2010), wherein the most affected breeds are Cocker Spaniel, Poodle, Doberman and Collie (ETTINGER; FELDMAN 2004; THRALL et al 2007.). There is no pathognomonic sign for the diagnosis of the immune-mediated hemolytic anemia; however, laboratory findings show regenerative anemia, spherocytosis, positive results in Coombs' test and rarely, monocytes with hemosiderin or erythrocytes phagocytosis, but even with these findings, the primary and secondary IMHA can not be differentiate from each other. Differentiation can only be achieved when there is a deep investigation into the cause of the anemia. The IMHA therapeutics starts with the support treatment and follows with an immunosuppressive therapy. In relation to IMHA Mortality rates, the numbers range from 25% to 50% (Thrall, 2007), or above 70% (CARR; Panciera; Kidd, 2002).